Diet composition for obesity-diabetes and production process thereof

Abstract

The invention discloses a diet formula for obesity-diabetes and a production process thereof, and belongs to the technical field of functional food, graded nutrition intervention is performed aiming at metabolic disorder levels of obesity-diabetes, and the diet formula is prepared through synergistic effects of 20-30 wt% of medicinal and edible components, 35 wt% of precise nutrition components and 35-45 wt% of low-GI value control components in combination with a specific processing process system. As a special medical food, a special dietary food or a composite nutritional meal, all-around intervention from lipid metabolism regulation and control, inflammation inhibition to intestinal barrier repair is realized, the FSMP national standard is met, and the blank of stage nutritional treatment of obesity-diabetes is filled up; the method serves as a core measure of an out-of-hospital management scheme of regular monitoring and evaluation of metabolic indexes, scientific exercise treatment and nutritional diet intervention of diabetic patients, and is combined with treatment dominated by traditional Chinese medicine in a hospital to form an in-hospital and out-of-hospital diabetes closed-loop management medical model.

Description

Technical Field

[0001] This invention belongs to the field of functional food technology, specifically relating to a dietary formula and production process for obese diabetes, which is suitable for outpatient nutritional management to improve insulin resistance, regulate lipid metabolism disorders and gut microbiota. Background Technology

[0002] Obesity-related diabetes mellitus (also known as obesity-related diabetes) is a common subtype of type 2 diabetes, characterized by obesity (especially central obesity) combined with insulin resistance and lipid metabolism disorders. Its pathogenesis is closely related to phlegm-dampness accumulation and liver stagnation and spleen deficiency. Clinically, it often manifests as abnormal glucose and lipid metabolism and intestinal microecological imbalance. With the rise in obesity rates, the incidence of this type of diabetes is showing a significant upward trend. Existing nutritional intervention methods, lacking the integration of traditional Chinese and Western medicine theories and precise classification strategies, are insufficient to effectively address its complex pathological mechanisms.

[0003] Currently, most commercially available nutritional products for obese diabetic patients are fortified with a single nutrient (such as dietary fiber or low-fat formula), which presents the following problems:

[0004] Without considering the metabolic regulatory functions of medicinal and edible herbs, the utilization rate of active ingredients in traditional Chinese medicine is low, and there is a lack of support from modern formulation technology.

[0005] The nutritional ratios were not adapted to different degrees of metabolic disorders (severe, moderate, and mild), and the graded formulas were not designed to address the dynamic pathogenesis of obesity-related diabetes (liver stagnation and spleen deficiency → phlegm obstruction → spleen and kidney qi deficiency).

[0006] It lacks targeted nutritional components for lipid oxidation and inflammation suppression, has not systematically integrated active ingredients of traditional Chinese medicine with precision nutrition modules, and has not established a graded intervention system.

[0007] Existing Foods for Special Medical Purposes (FSMP) mainly focus on calorie control, without systematically integrating active ingredients of traditional Chinese medicine with precision nutrition modules, and the production process does not differentiate between technical standards for FSMP, dietary foods, and compound nutritional diets. Summary of the Invention

[0008] The purpose of this invention is to provide a dietary formula and production process for obese diabetes based on the triple synergy of food and medicine homology, precision nutrition and low GI value control. It is suitable for outpatient nutritional management that improves insulin resistance, regulates lipid metabolism disorders and gut microbiota. The invention adapts to different degrees of metabolic disorders through a graded formula system and clarifies the differentiated production processes of three types of products (medical foods, dietary foods, and compound nutritional diets).

[0009] To address the aforementioned technical problems, this invention provides a dietary formula for obese diabetic patients, suitable for preparing special medical foods, special dietary foods, or compound nutritional meals, for outpatient nutritional management of obese diabetic patients, comprising:

[0010] The ingredients, which are derived from both food and medicine, include those that soothe the liver and regulate the body, strengthen the spleen and eliminate turbidity, promote the elimination of dampness in the three jiaos, combine tonification and purgation, and promote diuresis and elimination. They are used to regulate the complex pathogenesis of phlegm-dampness-liver stagnation-spleen deficiency in obese diabetes.

[0011] Precision nutritional components, including metabolic regulators, anti-inflammatory repairers, gut axis modulators, and / or physical barrier components, are used to target and improve insulin resistance and lipid metabolism disorders.

[0012] Low-GI control components, including slow-digesting carbohydrates and low-glycemic index vegetable powder, are used to slow down the rate of blood sugar rise.

[0013] The dietary formulas described above are graded according to the severity of metabolic disorders.

[0014] For severe metabolic disorders, the proportion of medicinal and food homologous components is 25-30 wt%, the proportion of precision nutrition components is 35 wt%, and the proportion of low GI value control components is 35-40 wt%.

[0015] For moderate metabolic disorders, the proportion of medicinal and edible homologous components is 20-25 wt%, and the proportion of low GI value control components is 40-45 wt%.

[0016] For mild metabolic disorders, the proportion of medicinal and edible components is 15-20 wt%, and the proportion of low-GI control components is 50-45 wt%.

[0017] Furthermore, for special medical foods, the medicinal and edible homologous components include 2 parts by weight of tangerine peel cell-wall broken powder, 2 parts by weight of bergamot β-cyclodextrin inclusion complex, 1 part by weight of hibiscus freeze-dried powder, 2 parts by weight of Japanese raisin tree extract, 2 parts by weight of poria cocos β-glucan, 2 parts by weight of coix seed γ-GABA enriched powder, 2 parts by weight of five-finger peach extract, 2 parts by weight of white hyacinth bean germination powder, 1 part by weight of geniposide, 1 part by weight of platycodon saponin, and kelp brown... 1 part by weight of fucoidan (chemical name: fucoidan sulfate, CAS: 9072-19-9), 1 part by weight of perilla seed ω-3 microemulsion, 1 part by weight of cordyceps militaris powder, 1 part by weight of black goji berry anthocyanin encapsulation, 2 parts by weight of processed polygonatum, 1 part by weight of ginseng and red ginseng honey-processed powder, 2 parts by weight of chicory probiotic inulin, 2 parts by weight of corn silk polysaccharide freeze-dried powder, 1 part by weight of hawthorn flavonoids, and 1 part by weight of malt α-amylase.

[0018] For special dietary foods, the medicinal and edible homologous components include 2 parts by weight of dried tangerine peel freeze-dried powder, 2 parts by weight of bergamot freeze-dried powder, 1 part by weight of roselle freeze-dried powder, 2 parts by weight of Japanese raisin tree extract, 2 parts by weight of Poria cocos β-glucan freeze-dried powder, 2 parts by weight of Coix seed γ-GABA freeze-dried powder, 2 parts by weight of five-finger peach freeze-dried powder, 2 parts by weight of white hyacinth bean freeze-dried powder, 1 part by weight of gardenia freeze-dried powder, 1 part by weight of platycodon root freeze-dried powder, 1 part by weight of kelp fucoidan freeze-dried powder, 1 part by weight of perilla seed freeze-dried powder, 1 part by weight of cordyceps militaris freeze-dried powder, 1 part by weight of black goji berry freeze-dried powder, 2 parts by weight of polygonatum rhizome freeze-dried powder, 1 part by weight of ginseng freeze-dried powder, 2 parts by weight of chicory freeze-dried powder, 2 parts by weight of corn silk freeze-dried powder, 1 part by weight of hawthorn freeze-dried powder, and 1 part by weight of malt freeze-dried powder.

[0019] For the compound nutritional diet, the medicinal and food homologous components include 2 parts by weight of dried tangerine peel slices, 2 parts by weight of Buddha's hand slices powder, 1 part by weight of dried roselle powder, 2 parts by weight of dried Japanese raisin tree fruit powder, 2 parts by weight of Poria cocos slices powder, 2 parts by weight of dried coix seed powder, 2 parts by weight of dried five-finger peach slices, 2 parts by weight of dried white hyacinth bean powder, 1 part by weight of dried gardenia slices powder, 1 part by weight of dried platycodon root slices powder, 1 part by weight of dried kelp powder, 1 part by weight of dried perilla seed powder, 1 part by weight of dried cordyceps militaris slices powder, 1 part by weight of dried black goji berry powder, 2 parts by weight of dried polygonatum rhizome powder, 1 part by weight of dried ginseng slices powder, 2 parts by weight of dried chicory powder, 2 parts by weight of dried corn silk powder, 1 part by weight of dried hawthorn slices powder, and 1 part by weight of dried malt powder.

[0020] Furthermore, the slow-digesting carbohydrates are selected from one or more of oats, oat dietary fiber, and konjac powder; the low glycemic index vegetable powder is selected from one or more of kelp powder, wheatgrass powder, celery powder, and spinach powder.

[0021] Furthermore, for foods for special medical use, the precise nutritional components include polyphenolic compounds (such as chlorogenic acid) and trace element Cr. 3+ (e.g., chromium picolinate, dichromium yeast powder), carotenoids (e.g., astaxanthin), curcumin derivatives (e.g., curcumin), probiotics (e.g., LP-Onlly and Bifidobacterium BB-12 combined probiotics), prebiotics (e.g., resistant dextrin RS4, arabinose, polysaccharides, etc.), medium-chain triglycerides (MCT) and / or water-soluble dietary fiber (e.g., konjac glucomannan). Chlorogenic acid has antioxidant, blood sugar and lipid-regulating effects, and can effectively improve insulin resistance, playing an important role in nutritional intervention for obesity-related diabetes; Cr 3+Astaxanthin helps enhance the effects of insulin, promotes glucose utilization and conversion, and is crucial for regulating blood sugar levels, thus assisting in improving glucose metabolism in diabetic patients. Astaxanthin possesses strong antioxidant capabilities, reducing inflammatory responses and protecting cells from oxidative damage, helping to alleviate oxidative stress in obese diabetic patients. Curcumin has anti-inflammatory, antioxidant, and lipid metabolism-regulating effects; its phospholipid complex form enhances its bioavailability, better exerting its therapeutic effect on obese diabetic patients. Probiotics can regulate the balance of intestinal flora, enhance intestinal barrier function, and improve the intestinal microecological environment, helping to control weight and regulate blood sugar. Prebiotics provide nutrients for probiotics, promoting their growth and reproduction, further regulating the intestinal microecology, and are of great significance for maintaining intestinal health and metabolic balance. Medium-chain triglycerides provide rapid energy and are not easily stored as fat in the body, helping to control weight and also having a positive effect on metabolic regulation. Water-soluble dietary fiber slows down the digestion and absorption of carbohydrates, reduces the rate of postprandial blood sugar rise, increases satiety, reduces food intake, and is beneficial for weight control.

[0022] For special dietary foods or compound nutritional diets, the precise nutritional components include protein powder (such as whey protein), peptides (such as sea cucumber peptides), and trace element Cr. 3+ It contains at least one of the following: prebiotics (such as guar gum), vitamins (such as vitamin C), and amino acids (such as taurine). Whey protein powder (high-quality protein) and sea cucumber peptides (active peptides) provide essential amino acids to maintain muscle mass and improve metabolic stress; taurine (an essential amino acid) participates in the regulation of myocardial function and antioxidation; vitamin C enhances immunity and assists in collagen synthesis.

[0023] The dietary formulation of this invention improves insulin resistance, regulates lipid metabolism disorders and gut microbiota through the synergistic effect of the three components. It adjusts the proportion of food-medicine homologous components according to the degree of metabolic disorder (severe, moderate and mild) in obese diabetic patients, and matches different doses of precise nutritional components and low-GI control components.

[0024] This invention also provides a production process for diets for obese type diabetics, employing different precision component processing technologies (nanoscale / ultramicroscale / ordinary scale) and active ingredient retention processes for special medical foods, special dietary foods, and compound nutritional diets.

[0025] For special medical foods: Buddha's hand extract is encapsulated with β-cyclodextrin to obtain Buddha's hand β-cyclodextrin inclusion complex; perilla seed ω-3 fatty acids are processed using microemulsification technology to obtain perilla seed ω-3 microemulsion with a particle size ≤200nm, the emulsifier for the microemulsification technology is Tween 80, and the pressure is 50MPa; black goji berry anthocyanins are encapsulated using natural polymer materials (such as sodium alginate and chitosan) to obtain black goji berry anthocyanin encapsulation; accurately weigh the following: tangerine peel cell wall breaking powder, Buddha's hand β-cyclodextrin inclusion complex, roselle freeze-dried powder, Japanese raisin tree extract, poria cocos β-glucan, coix seed γ-GABA enriched powder, five-finger peach extract, white hyacinth bean germination powder, geniposide, platycodon saponin, kelp fucoidan, perilla seed ω-3 microemulsion, cordyceps militaris powder, black goji berry anthocyanin encapsulation, and nine-times-processed yellow... The following ingredients are prepared and mixed evenly: refined ginseng and red ginseng honey-processed powder, chicory probiotic inulin, corn silk polysaccharide freeze-dried powder, hawthorn flavonoids, and malt α-amylase. Microcapsules are made by encapsulating the polyphenolic compounds of the precise nutritional components in sodium alginate-chitosan using spray drying microencapsulation technology. Probiotics are triple-encapsulated using calcium alginate-chitosan-pectin, resulting in a probiotic particle size ≤500nm and a gastric acid resistance survival rate ≥92%. Other precise nutritional components are accurately weighed and mixed evenly. Low-GI control components are pulverized to a particle size ≤50nm using nano-pulverization technology and mixed evenly in proportion. The medicinal and edible components, precise nutritional components, and low-GI control components are mixed evenly in proportion according to the level of metabolic disorder, and then sealed in aluminum foil bags using nitrogen-filled packaging technology.

[0026] For special dietary foods: The tangerine peel, a component with both medicinal and edible properties, is freeze-dried after low-temperature cell wall disruption. Other components, such as bergamot, roselle, poria cocos β-glucan, coix seed γ-GABA, five-finger peach, white hyacinth bean, gardenia, platycodon, kelp fucoidan, perilla seed, cordyceps militaris, black goji berry, polygonatum, ginseng, chicory, corn silk, hawthorn, and malt, are also freeze-dried separately and mixed evenly with jujube extract in a specific ratio. The precise nutritional components are ultra-finely pulverized to a particle size ≤50μm and mixed evenly. The low-GI control components are pulverized to a particle size ≤50nm using nano-pulverization technology and mixed evenly in a specific ratio. The medicinal and edible components, precise nutritional components, and low-GI control components are mixed evenly in a specific ratio according to the level of metabolic disorder, and then vacuum-packed into food-grade bags for sealing and storage.

[0027] For compound nutritional diets: The raw materials of the medicinal and edible components—dried tangerine peel, Buddha's hand, roselle, Japanese raisin tree fruit, poria cocos, coix seed, five-finger peach, white hyacinth bean, gardenia, platycodon root, kelp, perilla seed, cordyceps militaris, black goji berries, polygonatum, ginseng, chicory, corn silk, hawthorn, and malt—are routinely pulverized and sieved to produce fine or coarse powders, which are then mixed evenly according to a specified ratio. The raw materials of the precision nutritional components are routinely pulverized, sieved as required, and then mixed evenly. The low-GI control components are pulverized to a particle size ≤50nm using nano-pulverization technology and mixed evenly according to a specified ratio. The medicinal and edible components, precision nutritional components, and low-GI control components are mixed evenly according to the level of metabolic disorder and then sealed in composite film bags using standard packaging technology.

[0028] Supercritical CO2 extraction operates at a pressure range of 25–35 MPa, a temperature range of 40–45 °C, and an extraction time of 1.5–2 h, making it suitable for the extraction of heat-sensitive components. Nano-encapsulation technology uses natural polymers (such as sodium alginate and chitosan) as encapsulation materials, achieving an encapsulation rate ≥90% and a particle size ≤200 nm after encapsulation, making it suitable for the protection of probiotics and heat-sensitive nutrients. Spray drying operates at an inlet air temperature of 160–180 °C and an outlet air temperature of 70–80 °C. Freeze-drying operates at a vacuum degree of 10–20 Pa and a temperature of -50 to -40 °C, achieving an active ingredient retention rate ≥90%.

[0029] The production process of this invention achieves graded intervention for obese diabetic patients by controlling the proportion of medicinal and edible homologous components and the processing precision (nanoscale, ultra-microscale, and ordinary grade); and the products produced by this process have probiotics with triple encapsulation of calcium alginate and chitosan, with a gastric acid survival rate of ≥92%; and konjac glucomannan nanofibers can delay gastric emptying time by ≥2 hours.

[0030] The beneficial effects of this invention are:

[0031] Precisely regulate glucose and lipid metabolism disorders in obese diabetes by using a triple synergistic effect of food-medicine homologous components, precise nutritional fortification, and low-GI diet to improve insulin resistance, regulate lipid metabolism disorders, and improve gut microbiota.

[0032] The production process is green and environmentally friendly, employing modern formulation technologies such as supercritical extraction and nano-encapsulation to increase the utilization rate of active ingredients by 60%.

[0033] It complies with the National Catalogue of Foods and Medicines of the Same Origin and the Regulations on Foods for Special Medical Purposes (GB29922-2013), filling the gap in the staged nutritional therapy for obesity-related diabetes.

[0034] The probiotics are triple-encapsulated with calcium alginate and chitosan, increasing the gastric acid survival rate to 92%, ensuring effective colonization and function of the probiotics in the intestines.

[0035] Konjac glucomannan nanofibers can delay gastric emptying (prolonging gastric emptying time by ≥2 hours), which helps control blood sugar fluctuations. Detailed Implementation

[0036] The embodiments of the present invention will be described in detail below with reference to examples. However, those skilled in the art will understand that the following examples are only for illustrating the present invention and should not be regarded as limiting the scope of the present invention.

[0037] Example 1

[0038] This embodiment provides a special medical food (FSMP) formula for obese type diabetics with severe metabolic disorders, each bag containing 3.0g of food-medicine homology components, 3.5g of precise nutritional components and 3.5g of low GI value control components;

[0039] The medicinal and edible components include: Liver-soothing and regulating components: 0.2g of tangerine peel cell-wall broken powder, 0.2g of bergamot β-cyclodextrin inclusion complex, 0.1g of hibiscus freeze-dried powder, and 0.2g of Hovenia dulcis extract; Spleen-strengthening and turbidity-resolving components: 0.2g of Poria cocos β-glucan, 0.2g of Coix seed γ-GABA enriched powder, 0.2g of Ficus hirta extract, and 0.2g of white hyacinth bean germination powder; and Triple Burner-regulating components: 0.1g of geniposide. Platycodon saponins 0.1g, kelp fucoidan 0.1g, perilla seed ω-3 microemulsion 0.1g; Ingredients for both tonification and detoxification: Cordyceps militaris powder 0.1g, black goji berry anthocyanin encapsulation 0.1g, processed Polygonatum sibiricum 0.2g, ginseng and red ginseng honey-processed powder 0.2g; Ingredients for promoting digestion and eliminating dampness: chicory probiotic-converted inulin 0.2g, corn silk polysaccharide freeze-dried powder 0.2g, hawthorn flavonoids 0.1g, malt α-amylase 0.1g;

[0040] Precise nutritional components include: metabolic regulators: 50mg of chlorogenic acid (polyphenolic compound) microcapsules from green coffee beans, and chromium picolinate (Cr). 3+ 37.5μg; Anti-inflammatory and repairing components: curcumin phospholipid complex 75mg, astaxanthin microcapsule powder 1.5mg; Intestinal axis regulation: Lactobacillus plantarum LP-Onlly + Bifidobacterium BB-12 combined with probiotics (15×10 8 CFU), resistant dextrin RS4750mg, arabinoxylan 375mg, polydextrose 125mg, MCT microcapsule powder 625mg; physical barrier components: konjac glucomannan nanofiber 750mg, erythritol (sweetener) 125mg, phospholipids (food additive) 375mg, sodium carboxymethyl cellulose (food additive) 50mg.

[0041] The low-GI control components include: 1.0g oats, 1.0g oat dietary fiber, 0.8g konjac powder, 0.3g kelp powder, 0.2g wheatgrass powder, 0.1g celery powder, and 0.1g spinach powder.

[0042] Its production process includes the following steps:

[0043] S11, Processing of food-medicine homologous components:

[0044] The following ingredients were purchased commercially: tangerine peel cell wall broken powder, bergamot extract, roselle freeze-dried powder, Japanese raisin tree extract, poria cocos β-glucan, coix seed γ-GABA enriched powder, five-finger peach extract, white hyacinth bean germination powder, geniposide, platycodon saponin, kelp fucoidan, perilla seed ω-3 fatty acid, cordyceps militaris powder, black goji berry anthocyanin, nine-times-processed polygonatum, ginseng and red ginseng honey-processed powder, chicory probiotic inulin, corn silk polysaccharide freeze-dried powder, hawthorn flavonoids, and malt α-amylase.

[0045] β-Cyclodextrin inclusion complex of bergamot extract was obtained by encapsulation with β-cyclodextrin. The mass ratio of β-cyclodextrin to bergamot extract was 1:5. The encapsulation temperature was 50℃, the stirring speed was 300rpm, and the treatment time was 3h.

[0046] Black goji berry anthocyanins were obtained by chitosan encapsulation.

[0047] Perilla seed ω-3 fatty acids were processed using microemulsion technology to obtain perilla seed ω-3 microemulsion with a particle size ≤200nm. The emulsifier for the microemulsion technology was Tween 80 (5% by amount), and the pressure was 50MPa.

[0048] All other medicinal and edible components were purchased and used directly or after being nano-pulverized.

[0049] Mix the processed food and medicine homology components with the purchased food and medicine homology components in a certain proportion until they are evenly mixed.

[0050] S12, Precision nutrient component processing:

[0051] The chlorogenic acid from green coffee beans is microencapsulated using spray drying technology, with an inlet air temperature of 180℃ and an outlet air temperature of 80℃. The encapsulation material is sodium alginate-chitosan (1:1), and the encapsulation rate is ≥95%.

[0052] The combined probiotics Lactobacillus plantarum LP-Onlly and Bifidobacterium BB-12 are triple-encapsulated with calcium alginate, chitosan, and pectin layers, with a particle size ≤500nm and a gastric acid resistance survival rate ≥92%.

[0053] Konjac glucomannan was cyclicated three times under a homogeneous pressure of 150 MPa to prepare konjac glucomannan nanofibers with a fiber diameter of ≤50 nm.

[0054] The remaining precision nutrition components are all commercially available products;

[0055] The processed green coffee bean chlorogenic acid microcapsules, probiotic triple encapsulation, and other commercially available precision nutrient components are mixed evenly in proportion.

[0056] S13, Low GI value control component treatment:

[0057] Wheat seedlings were microwave-dried at 800W for 10 minutes until the moisture content was ≤6%.

[0058] Kelp was dried at a low temperature of 50℃ (wind speed 2m / s) until the moisture content was ≤6%;

[0059] Celery and spinach were dried in hot air at 60℃ for 4 hours until the moisture content was ≤8%;

[0060] Oat dietary fiber expands at a volume of ≥3 times after extrusion puffing, with an extrusion puffing machine screw speed of 200 rpm and a die temperature of 120℃.

[0061] The puffed oat dietary fiber, dried wheat sprouts, kelp, celery, spinach, oats, and konjac were pulverized to a particle size of ≤50nm using nano-pulverization technology and then mixed evenly in proportion.

[0062] S14. Mixed Packaging: Mix the food-medicine homology group, the precision nutrition group, and the low GI value control group evenly in a ratio of 30:35:35, use nitrogen-filled packaging technology, pack them into aluminum foil bags, and seal them for storage.

[0063] The core ingredients were tested:

[0064] The detection methods and results are shown in Table 1. Geniposide has anti-inflammatory and metabolic regulating effects. Its content in special medical foods was detected by HPLC (GB / T 22251), with a measured value of 9.5±0.3 mg / g, exceeding the standard requirement of ≥8 mg / g. This indicates that the product contains sufficient amounts of this component to effectively exert its metabolic regulating effects. Fucoidan has lipid-lowering and gut microbiota-improving functions. The measured content was 18.2±0.5%, reaching the standard of ≥15%, indicating that the product possesses the material basis for regulating lipid metabolism disorders and improving the gut environment. The survival rate of Bifidobacteria is related to the gut microbiota regulation effect. The test results during the shelf life exceeded the standard requirements, indicating that the product can effectively maintain the number of beneficial bacteria in the gut and promote gut health. Meanwhile, the compliance of the core component detection results reflects the effectiveness of the production process in component extraction and preservation. Supercritical fluid extraction and nano-encapsulation processes ensure the content and activity of components such as geniposide and fucoidan, ensuring stable product quality.

[0065] Table 1. Results of Core Component Detection

[0066]

[0067] Stability test:

[0068] The test results are shown in Table 2. The retention rate of active ingredients was ≥88% in the accelerated test (40℃ / RH 75%, 6 months) and ≥92% in the long-term test (25℃ / 12 months). This indicates that the active ingredients can maintain a high proportion under different storage conditions and will not decompose or become inactive rapidly, ensuring that they can continuously provide stable nutritional intervention for patients within the shelf life and maintain the product's efficacy. The survival rate of probiotics was ≥85% in the accelerated test and ≥90% in the long-term test, indicating that the probiotics treated with the special encapsulation process can maintain high activity, ensuring that the product can effectively regulate the intestinal microecology, enhance the intestinal barrier function, and maintain intestinal health within the shelf life. The peroxide value of astaxanthin was ≤5 meq / kg in both the accelerated and long-term tests, indicating that the product has good antioxidant stability and that components such as oils are not excessively oxidized to produce harmful substances, ensuring the safety of the product and reducing the potential risks of oxidation products to human health.

[0069] Table 2 Stability Test Results

[0070]

[0071] Example 2

[0072] This embodiment provides a special medical food (FSMP) formula for obese type diabetics with moderate metabolic disorders, each bag containing 2.5g of food-medicine homology components, 3.5g of precise nutritional components and 4.0g of low GI value control components;

[0073] The medicinal and edible components include: 167mg of cell wall broken tangerine peel powder, 167mg of bergamot β-cyclodextrin inclusion complex, 83mg of hibiscus freeze-dried powder, 167mg of Hovenia dulcis triterpenoid extract, 167mg of Poria cocos β-glucan, 167mg of Coix lacryma-jobi γ-GABA enriched powder, 167mg of Ficus hirta extract, 167mg of white hyacinth bean germination powder, 83mg of geniposide, 83mg of platycodon saponin, 83mg of kelp fucoidan, 83mg of perilla seed ω-3 microemulsion, 83mg of Cordyceps militaris powder, 83mg of black goji berry anthocyanin encapsulation, 167mg of processed Polygonatum sibiricum powder, 83mg of honey-processed ginseng and red ginseng powder, 167mg of inulin converted by chicory probiotics, 167mg of freeze-dried corn silk polysaccharide powder, 83mg of hawthorn flavonoids, and 83mg of malt α-amylase.

[0074] Precise nutritional components include: 50mg chlorogenic acid microcapsules from green coffee beans, 37.5μg chromium picolinate, 75mg curcumin phospholipid complex, 1.5mg astaxanthin triple microcapsules, 4750mg resistant dextrin, 375mg arabinoxylan, and 15×10⁻⁶ Lactobacillus plantarum LP-Onlly + Bifidobacterium BB-12. 8CFU), konjac glucomannan nanofibers 750mg, MCT microcapsule powder 625mg, erythritol 125mg, polydextrose 125mg, phospholipids 375mg, sodium carboxymethyl cellulose 50mg;

[0075] The low-GI control components include: 1.14g oats, 1.14g oat dietary fiber, 0.91g konjac powder, 0.34g kelp powder, 0.23g wheatgrass powder, 0.11g celery powder, and 0.11g spinach powder.

[0076] Its production process includes the following steps:

[0077] S11, Processing of food-medicine homologous components:

[0078] Referring to the processing technology of food-medicine homology components in Example 1, the dosage of each component was adjusted proportionally;

[0079] S12. Precise nutrient component processing: Same as in Example 1, directly mix evenly;

[0080] S13, Low GI value control component treatment:

[0081] Adjust the proportions of oats, oat dietary fiber, konjac powder, kelp powder, wheatgrass powder, celery powder, and spinach powder, and mix them evenly.

[0082] S14. Mixed Packaging: Mix the medicinal and edible components, precise nutritional components, and low GI value control components evenly in a ratio of 25:35:40, use nitrogen-filled packaging technology, pack them into aluminum foil bags, and seal them for storage.

[0083] Example 3

[0084] This embodiment provides a special medical food (FSMP) formula for mild metabolic disorders in obese type diabetics, each bag containing 2.0g of food-medicine homology components, 3.5g of precise nutritional components and 4.5g of low GI value control components;

[0085] The medicinal and edible components include: 133mg of tangerine peel cell wall broken powder, 133mg of bergamot β-cyclodextrin inclusion complex, 67mg of hibiscus freeze-dried powder, 133mg of Japanese raisin tree extract, 133mg of poria cocos β-glucan, 133mg of coix seed γ-GABA enriched powder, 133mg of five-finger peach extract, 133mg of white hyacinth bean germination powder, 67mg of geniposide, 67mg of platycodon saponin, 67mg of kelp fucoidan, 67mg of perilla seed ω-3 microemulsion, 67mg of cordyceps militaris powder, 67mg of black goji berry anthocyanin encapsulation, 133mg of nine-times-processed polygonatum powder, 67mg of ginseng and red ginseng honey-processed powder, 133mg of chicory probiotic inulin, 133mg of corn silk polysaccharide freeze-dried powder, 67mg of hawthorn flavonoids, and 67mg of malt α-amylase.

[0086] Precise nutritional components include: 50mg of chlorogenic acid microcapsules from green coffee beans, and 0.3mg of chromium picolinate (containing Cr). 3+ 37.5μg), curcumin phospholipid complex 75mg, astaxanthin triple microcapsules 1.5mg, resistant dextrin RS4750mg, arabinoxylan 375mg, Lactobacillus plantarum LP-Onlly + Bifidobacterium BB-12 compound bacterial agent 200mg (live count 15×10⁻⁶) 8 CFU), konjac glucomannan nanofibers 750mg, MCT microcapsule powder 625mg, erythritol 125mg, polydextrose 125mg, phospholipids 375mg, sodium carboxymethyl cellulose 50mg;

[0087] The low-GI control components include: 1.29g oats, 1.29g oat dietary fiber, 1.03g konjac powder, 0.39g kelp powder, 0.26g wheatgrass powder, 0.13g celery powder, and 0.13g spinach powder.

[0088] Its production process includes the following steps:

[0089] S11, Processing of food-medicine homologous components:

[0090] Referring to the processing technology of food-medicine homology components in Example 1, the dosage of each component was adjusted proportionally;

[0091] S12. Precise nutrient component processing: Same as in Example 1, directly mix evenly;

[0092] S13, Low GI value control component treatment:

[0093] Adjust the proportions of oats, oat dietary fiber, konjac powder, kelp powder, wheatgrass powder, celery powder, and spinach powder, and mix them evenly.

[0094] S14. Mixed Packaging: Mix the medicinal and edible components, precise nutritional components, and low GI value control components evenly in a ratio of 20:35:45, use nitrogen-filled packaging technology, pack them into aluminum foil bags, and seal them for storage.

[0095] Example 4

[0096] This embodiment provides a special dietary food formula for obese type diabetics with severe metabolic disorders. Each bag contains 3.0g of food-medicine homology components, 3.5g of precise nutritional components, and 3.5g of low GI value control components.

[0097] The medicinal and edible components include: 0.2g of dried tangerine peel freeze-dried powder, 0.2g of bergamot freeze-dried powder, 0.1g of roselle freeze-dried powder, 0.2g of Japanese raisin tree extract, 0.2g of poria cocos β-glucan freeze-dried powder, 0.2g of coix seed γ-GABA freeze-dried powder, 0.2g of five-finger peach freeze-dried powder, 0.2g of white hyacinth bean freeze-dried powder, 0.1g of gardenia freeze-dried powder, 0.1g of platycodon root freeze-dried powder, 0.1g of kelp fucoidan freeze-dried powder, 0.1g of perilla seed freeze-dried powder, 0.1g of cordyceps militaris freeze-dried powder, 0.1g of black goji berry freeze-dried powder, 0.2g of polygonatum rhizome freeze-dried powder, 0.2g of ginseng freeze-dried powder, 0.2g of chicory freeze-dried powder, 0.2g of corn silk freeze-dried powder, 0.1g of hawthorn freeze-dried powder, and 0.1g of malt freeze-dried powder.

[0098] The precise nutritional components include: 1.19g of ultrafine whey protein powder, 0.56g of sea cucumber peptide powder, and 0.17g of chromium-enriched yeast powder (containing Cr). 3+ 170μg), Haematococcus pluvialis powder (carotenoid) 0.28g, arabinoxylan (prebiotic) 0.85g, erythritol (sweetener) 0.17g, polydextrose (prebiotic) 0.28g;

[0099] The low-GI control components include: 1.0g oats, 1.0g oat dietary fiber, 0.8g konjac powder, 0.3g kelp powder, 0.2g wheatgrass powder, 0.1g celery powder, and 0.1g spinach powder.

[0100] Its production process includes the following steps:

[0101] S21. Processing of food-medicine homologous components:

[0102] The dried tangerine peel is subjected to low-temperature cell wall breaking under a pressure of 0.8 MPa and then freeze-dried under vacuum to obtain tangerine peel freeze-dried powder;

[0103] Five-finger peach was freeze-dried at 15 Pa vacuum and -40 ℃ to obtain peach freeze-dried powder, with an active substance retention rate of ≥90%.

[0104] Cordyceps militaris powder was freeze-dried under vacuum at 20 Pa and -45 °C to obtain freeze-dried Cordyceps militaris powder.

[0105] Mix the freeze-dried tangerine peel powder, freeze-dried five-finger peach powder, freeze-dried cordyceps powder and other food and medicine homologous components (purchased commercially) in a certain proportion;

[0106] S22, Precision nutrient component processing:

[0107] Whey protein was ultra-finely pulverized to a particle size of ≤50μm using an air jet mill with a pressure of 0.7MPa and a classifying wheel speed of 12000rpm to obtain ultra-fine whey protein powder.

[0108] Haematococcus pluvialis was spray-dried to a moisture content of ≤5%, with an inlet air temperature of 160℃ and an outlet air temperature of 70℃.

[0109] Mix whey protein ultrafine powder, dried Haematococcus pluvialis, sea cucumber peptides, chromium-enriched yeast, arabinoxylan, erythritol, and polydextrose evenly.

[0110] S23. Low GI value control component treatment: Same as in Example 1;

[0111] S24. Mixed Packaging: Mix the medicinal and edible components, precise nutritional components, and low GI value control components evenly in a ratio of 30:35:35, use vacuum packaging technology, pack them into food-grade packaging bags, and seal them for storage.

[0112] Example 5

[0113] This embodiment provides a special dietary food formula for moderate metabolic disorders in obese type diabetics, each bag containing 2.5g of food-medicine homology components, 3.5g of precise nutritional components and 4.0g of low GI value control components;

[0114] The medicinal and edible components include: 167mg of dried tangerine peel freeze-dried powder, 167mg of bergamot freeze-dried powder, 83mg of roselle freeze-dried powder, 167mg of Japanese raisin tree extract, 167mg of poria cocos β-glucan freeze-dried powder, 167mg of coix seed γ-GABA freeze-dried powder, 167mg of five-finger peach freeze-dried powder, 167mg of white hyacinth bean freeze-dried powder, 83mg of gardenia freeze-dried powder, 83mg of platycodon root freeze-dried powder, 83mg of kelp fucoidan freeze-dried powder, 83mg of perilla seed freeze-dried powder, 83mg of cordyceps militaris freeze-dried powder, 83mg of black goji berry freeze-dried powder, 167mg of polygonatum rhizome freeze-dried powder, 83mg of ginseng freeze-dried powder, 167mg of chicory freeze-dried powder, 167mg of corn silk freeze-dried powder, 83mg of hawthorn freeze-dried powder, and 83mg of malt freeze-dried powder.

[0115] The precise nutritional components include: 1.43g of whey protein ultrafine powder, 0.4g of taurine (amino acid) ultrafine powder, 0.24g of chromium-enriched yeast powder, 0.4g of Haematococcus pluvialis powder, 0.8g of arabinoxylan, and 0.23g of sodium carboxymethyl cellulose;

[0116] The low-GI control components include: 1.14g oats, 1.14g oat dietary fiber, 0.91g konjac powder, 0.34g kelp powder, 0.23g wheatgrass powder, 0.11g celery powder, and 0.11g spinach powder.

[0117] Its production process includes the following steps:

[0118] S21. Processing of food-medicine homologous components:

[0119] Referring to the processing technology of food and medicine homology components in Example 4, the cell wall breaking pressure was adjusted to 0.7 MPa, the freeze drying temperature was -40°C, and the dosage of each component was adjusted proportionally.

[0120] S22. Precise nutrient component processing: Whey protein and Haematococcus pluvialis are processed according to the process in Example 4 and mixed evenly with taurine, chromium-enriched yeast, arabinoxylan and sodium carboxymethyl cellulose.

[0121] S23. Low GI value control component treatment: Same as in Example 2;

[0122] S24. Mixed Packaging: Mix the medicinal and edible components, precise nutritional components, and low GI value control components evenly in a ratio of 25:35:40, use vacuum packaging technology, pack them into food-grade packaging bags, and seal them for storage.

[0123] Example 6

[0124] This embodiment provides a special dietary food formula for mild metabolic disorders in obese type diabetics, each bag containing 2.0g of food-medicine homology components, 3.5g of precise nutritional components and 4.5g of low GI value control components;

[0125] The medicinal and edible components include: 133mg of dried tangerine peel freeze-dried powder, 133mg of dried Buddha's hand freeze-dried powder, 67mg of dried roselle freeze-dried powder, 133mg of dried Japanese raisin tree extract, 133mg of dried poria cocos β-glucan freeze-dried powder, 133mg of dried coix seed γ-GABA freeze-dried powder, 133mg of dried five-finger peach freeze-dried powder, 133mg of dried white hyacinth bean freeze-dried powder, 67mg of dried gardenia fruit freeze-dried powder, 67mg of dried platycodon root freeze-dried powder, 67mg of dried kelp fucoidan freeze-dried powder, 67mg of dried perilla seed freeze-dried powder, 67mg of dried cordyceps militaris freeze-dried powder, 67mg of dried black goji berry freeze-dried powder, 133mg of dried polygonatum rhizome freeze-dried powder, 67mg of dried ginseng freeze-dried powder, 133mg of dried chicory freeze-dried powder, 133mg of dried corn silk freeze-dried powder, 67mg of dried hawthorn fruit freeze-dried powder, and 67mg of dried malt freeze-dried powder.

[0126] The precise nutritional components include: 2.0g whey protein powder, 1.0g sea cucumber powder, 0.3g taurine powder, and 0.2g steviol glycosides (sweetener);

[0127] The low-GI control components include: 1.29g oats, 1.29g oat dietary fiber, 1.03g konjac powder, 0.39g kelp powder, 0.26g wheatgrass powder, 0.13g celery powder, and 0.13g spinach powder.

[0128] Its production process includes the following steps:

[0129] S21. Processing of food-medicine homologous components:

[0130] Referring to the processing technology of food and medicine homology components in Example 4, the cell wall breaking pressure was adjusted to 0.6 MPa, the freeze drying temperature was -35°C, and the dosage of each component was adjusted proportionally.

[0131] S22, Precision nutrient component processing:

[0132] Whey protein, sea cucumber and taurine were pulverized to a particle size ≤150μm;

[0133] Using a V-type mixer, adjust the speed to 20 rpm and the time to 30 minutes, mix steviol glycosides with whey protein powder, sea cucumber powder and taurine powder evenly (CV value ≦5%).

[0134] S23. Low GI value control component treatment: Same as in Example 3;

[0135] S24. Mixed Packaging: Mix the medicinal and edible components, precise nutritional components, and low GI value control components evenly in a ratio of 20:35:45, use vacuum packaging technology, pack them into food-grade packaging bags, and seal them for storage.

[0136] Example 7

[0137] This embodiment provides a compound nutritional diet formula for severe metabolic disorders in obese type diabetes, each bag containing 3.0g of food and medicine homology components, 3.5g of precise nutritional components and 3.5g of low GI value control components;

[0138] The medicinal and edible components include: 0.2g of finely powdered dried tangerine peel (passed through an 80-mesh sieve), 0.2g of powdered Buddha's hand citron, 0.1g of dried roselle powder, 0.2g of coarse powdered Japanese raisin tree fruit, 0.2g of powdered poria cocos (particle size ≤200μm), 0.2g of coarse powdered coix seed, 0.2g of powdered five-finger peach, 0.2g of coarse powdered white hyacinth bean, 0.1g of powdered gardenia, 0.1g of powdered platycodon grandiflorum (particle size ≤180μm), 0.1g of coarse powdered kelp, 0.1g of coarse powdered perilla seed, 0.1g of powdered cordyceps militaris, 0.1g of dried black goji berry powder, 0.2g of powdered polygonatum, 0.2g of powdered ginseng, 0.2g of coarse powdered chicory, 0.2g of coarse powdered corn silk, 0.1g of powdered hawthorn, and 0.1g of coarse powdered malt.

[0139] The precise nutritional components include: 2.1g of whey protein powder (WPC 80%), 1.0g of sea cucumber powder, and 0.3g of chromium-enriched yeast powder (containing Cr). 3+ 300μg), steviol glycosides 0.1g;

[0140] The low-GI control components include: 1.0g oats, 1.0g oat dietary fiber, 0.8g konjac powder, 0.3g kelp powder, 0.2g wheatgrass powder, 0.1g celery powder, and 0.1g spinach powder.

[0141] Its production process includes the following steps:

[0142] S31. Processing of food-medicine homologous components:

[0143] After screening, washing, and drying the dried tangerine peel, Buddha's hand, roselle, Japanese raisin tree fruit, poria cocos, coix seed, five-finger peach, white hyacinth bean, gardenia, platycodon root, kelp, perilla seed, cordyceps militaris, black goji berry, polygonatum rhizome, ginseng, chicory, corn silk, hawthorn, and malt, they are pulverized using a hammer mill and passed through an 80-mesh sieve to obtain fine or coarse powder of the medicinal slices.

[0144] S32. Precise nutrient component processing: Whey protein, sea cucumber, chromium-enriched yeast, and steviol glycosides are pulverized into ordinary powder, passed through a 60-mesh sieve, and mixed evenly;

[0145] S33, Low GI value control component treatment: Same as in Example 1;

[0146] S34. Mixed Packaging: Mix the medicinal and edible components, precise nutritional components, and low GI value control components evenly in a ratio of 30:35:35, pack them into a composite film bag using ordinary packaging technology, and seal them for storage.

[0147] Example 8

[0148] This embodiment provides a compound nutritional diet formula for moderate metabolic disorders in obese type diabetics, each bag containing 2.5g of food and medicine homology components, 3.5g of precise nutritional components and 4.0g of low GI value control components;

[0149] The medicinal and edible components include: 167mg of fine powdered dried tangerine peel, 167mg of powdered Buddha's hand citron, 83mg of dried roselle powder, 167mg of coarse powdered Japanese raisin tree fruit, 167mg of powdered poria cocos, 167mg of coarse powdered coix seed, 167mg of powdered five-finger peach, 167mg of coarse powdered white hyacinth bean, 83mg of powdered gardenia, 83mg of powdered platycodon root, 83mg of coarse powdered kelp, 83mg of coarse powdered perilla seed, 83mg of powdered cordyceps militaris, 83mg of dried black goji berry powder, 167mg of powdered polygonatum rhizome, 83mg of powdered ginseng, 167mg of coarse powdered chicory, 167mg of coarse powdered corn silk, 83mg of powdered hawthorn, and 83mg of coarse powdered malt.

[0150] The precise nutritional components include: 1.5g whey protein powder, 1.0g polydextrose, 0.5g sodium carboxymethyl cellulose, and 0.5g vitamin C powder;

[0151] The low-GI control components include: 1.14g oats, 1.14g oat dietary fiber, 0.91g konjac powder, 0.34g kelp powder, 0.23g wheatgrass powder, 0.11g celery powder, and 0.11g spinach powder.

[0152] Its production process includes the following steps:

[0153] S31. Processing of food-medicine homologous components:

[0154] Referring to the processing technology of food and medicine homology components in Example 7, each raw material is pulverized and passed through an 80-mesh sieve, and the amount of each component is adjusted according to the proportion.

[0155] S32. Precise nutrient component processing: Whey protein, polydextrose, sodium carboxymethyl cellulose, and vitamin C are pulverized into ordinary powder and passed through a 60-mesh sieve; sodium carboxymethyl cellulose is first dissolved in water at a water-to-material ratio of 1:3, with a stirring speed of 500 rpm and a dissolution temperature of 50℃, and then mixed evenly with whey protein ordinary powder, polydextrose, and vitamin C in proportion.

[0156] S33, Low GI value control component treatment: Same as in Example 2;

[0157] S34. Mixed Packaging: Mix the medicinal and edible components, precise nutritional components, and low GI value control components evenly in a ratio of 25:35:40, pack them into composite film bags using ordinary packaging technology, and seal them for storage.

[0158] Example 9

[0159] This embodiment provides a compound nutritional diet formula for mild metabolic disorders in obese type diabetes, each bag containing 2.0g of food and medicine homology components, 3.5g of precise nutritional components and 4.5g of low GI value control components;

[0160] The medicinal and edible components include: 133mg of fine powdered dried tangerine peel, 133mg of powdered Buddha's hand citron, 67mg of dried roselle powder, 133mg of coarse powdered Japanese raisin tree fruit, 133mg of powdered poria cocos, 133mg of coarse powdered coix seed, 133mg of powdered five-finger peach, 133mg of coarse powdered white hyacinth bean, 67mg of powdered gardenia, 67mg of powdered platycodon root, 67mg of coarse powdered kelp, 67mg of coarse powdered perilla seed, 67mg of powdered cordyceps militaris, 67mg of dried black goji berry powder, 133mg of powdered polygonatum rhizome, 67mg of powdered ginseng, 133mg of coarse powdered chicory, 133mg of coarse powdered corn silk, 67mg of powdered hawthorn, and 67mg of coarse powdered malt.

[0161] The precise nutritional components include: 2.0g whey protein powder, 1.0g polydextrose, 0.3g sodium carboxymethyl cellulose, and 0.2g guar gum;

[0162] The low-GI control components include: 1.29g oats, 1.29g oat dietary fiber, 1.03g konjac powder, 0.39g kelp powder, 0.26g wheatgrass powder, 0.13g celery powder, and 0.13g spinach powder.

[0163] Its production process includes the following steps:

[0164] S31. Processing of food-medicine homologous components:

[0165] Referring to the processing technology of food and medicine homology components in Example 7, each raw material is pulverized and passed through an 80-mesh sieve, and the amount of each component is adjusted according to the proportion.

[0166] S32, Precision nutrient component processing:

[0167] Whey protein, polydextrose, and sodium carboxymethyl cellulose were pulverized into ordinary powder and passed through an 80-mesh sieve.

[0168] A practical double-helix mixer was used to mix guar gum with whey protein powder, polydextrose and sodium carboxymethyl cellulose in a certain proportion, at a speed of 15 rpm for 20 minutes.

[0169] S33, Low GI value control component treatment: Same as in Example 3;

[0170] S34. Mixed Packaging: Mix the medicinal and edible components, precise nutritional components, and low GI value control components evenly in a ratio of 20:35:45, use ordinary packaging technology, pack them into composite film bags, and seal them for storage.

[0171] The above embodiments are only used to illustrate the technical solutions of the present invention, and are not intended to limit them; those skilled in the art should understand that modifications can still be made to the technical solutions described in the foregoing embodiments, or equivalent substitutions can be made to some of the technical features; and these modifications or substitutions will not cause the essence of the corresponding technical solutions to deviate from the protection scope of the present invention.

Claims

1. A dietary formula for obese-type diabetes, suitable for preparing special medical foods, special dietary foods, or compound nutritional diets, characterized in that, include: The ingredients are derived from both food and medicine, including those that soothe the liver and regulate the body, strengthen the spleen and eliminate turbidity, promote the elimination of dampness in the three jiaos, combine tonification and purgation, and promote digestion and eliminate dampness. Precise nutritional components, including metabolic regulation, anti-inflammatory repair, gut axis regulation and / or physical barrier components; Low GI controlled components, including slow-digesting carbohydrates and low glycemic index vegetable powder; The dietary formulas described above are graded according to the severity of metabolic disorders. For severe metabolic disorders, the proportion of medicinal and food homologous components is 25-30 wt%, the proportion of precision nutrition components is 35 wt%, and the proportion of low GI value control components is 35-40 wt%. For moderate metabolic disorders, the proportion of medicinal and edible homologous components is 20-25 wt%, and the proportion of low GI value control components is 40-45 wt%. For mild metabolic disorders, the proportion of medicinal and edible components is 15-20 wt%, and the proportion of low-GI control components is 50-45 wt%.

2. The dietary formula according to claim 1, characterized in that: The medicinal and edible components include 2 parts by weight of tangerine peel cell wall-breaking powder, 2 parts by weight of bergamot β-cyclodextrin inclusion complex, 1 part by weight of roselle freeze-dried powder, 2 parts by weight of Japanese raisin tree extract, 2 parts by weight of poria cocos β-glucan, 2 parts by weight of coix seed γ-GABA enriched powder, 2 parts by weight of five-finger peach extract, 2 parts by weight of white hyacinth bean germination powder, 1 part by weight of geniposide, 1 part by weight of platycodon saponin, 1 part by weight of kelp fucoidan, 1 part by weight of perilla seed ω-3 microemulsion, 1 part by weight of cordyceps militaris powder, 1 part by weight of black goji berry anthocyanin encapsulation, 2 parts by weight of processed polygonatum, 1 part by weight of ginseng and red ginseng honey-processed powder, 2 parts by weight of chicory probiotics converted inulin, 2 parts by weight of corn silk polysaccharide freeze-dried powder, 1 part by weight of hawthorn flavonoids, and 1 part by weight of malt α-amylase.

3. The dietary formula according to claim 1, characterized in that: The medicinal and edible components include 2 parts by weight of dried tangerine peel freeze-dried powder, 2 parts by weight of dried Buddha's hand freeze-dried powder, 1 part by weight of dried roselle freeze-dried powder, 2 parts by weight of Hovenia dulcis extract, 2 parts by weight of Poria cocos β-glucan freeze-dried powder, 2 parts by weight of Coix seed γ-GABA freeze-dried powder, 2 parts by weight of dried five-finger peach freeze-dried powder, 2 parts by weight of dried white hyacinth bean freeze-dried powder, 1 part by weight of dried gardenia freeze-dried powder, 1 part by weight of dried platycodon root freeze-dried powder, 1 part by weight of dried kelp fucoidan freeze-dried powder, 1 part by weight of dried perilla seed freeze-dried powder, 1 part by weight of dried cordyceps militaris freeze-dried powder, 1 part by weight of dried black goji berry freeze-dried powder, 2 parts by weight of dried polygonatum rhizome freeze-dried powder, 1 part by weight of dried ginseng freeze-dried powder, 2 parts by weight of dried chicory freeze-dried powder, 2 parts by weight of dried corn silk freeze-dried powder, 1 part by weight of dried hawthorn freeze-dried powder, and 1 part by weight of dried malt freeze-dried powder.

4. The dietary formula according to claim 1, characterized in that: The medicinal and edible components include 2 parts by weight of dried tangerine peel slices, 2 parts by weight of Buddha's hand slices powder, 1 part by weight of dried roselle powder, 2 parts by weight of coarse powder of Japanese raisin tree fruit, 2 parts by weight of dried tangerine peel slices powder, 2 parts by weight of coarse powder of poria cocos, 2 parts by weight of coarse powder of coix seed, 2 parts by weight of dried shiitake mushroom slices, 2 parts by weight of coarse powder of white hyacinth bean, 1 part by weight of dried tangerine peel slices powder, 1 part by weight of dried tangerine peel slices powder, 1 part by weight of dried tangerine peel slices powder, 1 part by weight of coarse powder of platycodon root slices, 1 part by weight of coarse powder of kelp, 1 part by weight of coarse powder of perilla seed, 1 part by weight of dried tangerine peel slices powder of cordyceps militaris, 1 part by weight of dried black goji berry powder, 2 parts by weight of dried scutellaria baicalensis slices powder, 1 part by weight of dried ginseng slices powder, 2 parts by weight of coarse powder of chicory, 2 parts by weight of coarse powder of corn silk, 1 part by weight of dried tangerine peel slices powder, and 1 part by weight of coarse powder of malt.

5. The dietary formulation according to any one of claims 2 to 4, characterized in that: The slow-digesting carbohydrates include 10 parts by weight of oats, 10 parts by weight of oat dietary fiber, and 8 parts by weight of konjac flour; The low glycemic index vegetable powder includes 3 parts by weight of kelp powder, 2 parts by weight of wheatgrass powder, 1 part by weight of celery powder, and 1 part by weight of spinach powder.

6. The dietary formula according to claim 5, characterized in that: The precise nutritional components include polyphenolic compounds and trace element Cr. 3+ Carotenoids, curcumin derivatives, probiotics, prebiotics, medium-chain triglycerides and / or water-soluble dietary fiber.

7. The dietary formula according to claim 5, characterized in that: The precise nutritional components include protein powder, sea cucumber peptides, and trace element Cr. 3+ It contains at least one of the following: prebiotics, vitamins, and amino acids.

8. The production process of the diet according to claim 6, characterized in that, Includes the following steps: S11, Processing of food-medicine homologous components: Buddha's Hand extract was used to obtain Buddha's Hand β-cyclodextrin inclusion complexes by β-cyclodextrin encapsulation; Perilla seed ω-3 fatty acids were processed using microemulsion technology to obtain perilla seed ω-3 microemulsion with a particle size ≤200nm; Black goji berry anthocyanins were obtained by encapsulating them with natural polymer materials. Accurately weigh the following ingredients: tangerine peel cell wall broken powder, bergamot β-cyclodextrin inclusion complex, roselle freeze-dried powder, Japanese raisin tree extract, poria cocos β-glucan, coix seed γ-GABA enriched powder, five-finger peach extract, white hyacinth bean germination powder, geniposide, platycodon saponin, kelp fucoidan, perilla seed ω-3 microemulsion, cordyceps militaris powder, black goji berry anthocyanin encapsulation, nine-times-processed polygonatum, ginseng and red ginseng honey-processed powder, chicory probiotic inulin, corn silk polysaccharide freeze-dried powder, hawthorn flavonoids and malt α-amylase, and mix them evenly according to the specified proportions. S12. Precision nutrient component processing: Polyphenolic compounds are encapsulated in sodium alginate-chitosan using spray drying microencapsulation technology to form microcapsules; Probiotics are triple-encapsulated using calcium alginate-chitosan-pectin, with a particle size of ≤500nm and a gastric acid resistance survival rate of ≥92% after encapsulation; Precision nutrient components are accurately weighed and mixed evenly. S13. Treatment of low GI value control components: The low GI value control components are pulverized to a particle size ≤50nm using nano-pulverization technology and then mixed evenly in proportion. S14. Mixing: Mix the medicinal and edible components, precise nutritional components, and low-GI control components in proportion according to the level of metabolic disorder, and then pack them into aluminum foil bags for sealing and storage using nitrogen-filled packaging technology.

9. The production process for the dietary supplement for obese type diabetics according to claim 7, characterized in that, Includes the following steps: S21. Processing of medicinal and edible homologous components: Tangerine peel, Buddha's hand, roselle, Poria β-glucan, Coix seed γ-GABA, Five-finger peach, white hyacinth bean, gardenia, platycodon, kelp fucoidan, perilla seed, cordyceps militaris, black goji berry, polygonatum, ginseng, chicory, corn silk, hawthorn and malt are vacuum freeze-dried to make freeze-dried powder, and then mixed evenly with Hovenia dulcis extract in a certain proportion; S22. Precision nutrient component processing: The precision nutrient components are ultra-finely pulverized to a particle size ≤50μm and mixed evenly; S23. Treatment of low GI value control components: The low GI value control components are pulverized to a particle size ≤50nm using nano-pulverization technology and then mixed evenly in proportion. S24. Mixing: Mix the medicinal and edible components, precise nutritional components, and low-GI control components in proportion according to the level of metabolic disorder, and then seal them in food-grade packaging bags using vacuum packaging technology.

10. The production process for the diet for obese type diabetics according to claim 7, characterized in that, Includes the following steps: S31. Processing of medicinal and edible components: The following ingredients are ground and sieved to make fine powder or coarse powder for medicinal use: dried tangerine peel, Buddha's hand, roselle, Japanese raisin tree fruit, poria cocos, coix seed, five-finger peach, white hyacinth bean, gardenia, platycodon root, kelp, perilla seed, cordyceps militaris, black goji berry, polygonatum, ginseng, chicory, corn silk, hawthorn, and malt. They are then mixed evenly in proportion. S32. Precision nutrient component processing: The precision nutrient component raw materials are pulverized in ordinary way, sieved as required, and then mixed evenly. S33. Treatment of low GI value control components: The low GI value control components are pulverized to a particle size ≤50nm using nano-pulverization technology and then mixed evenly in proportion. S34. Mixing: Mix the medicinal and edible components, precise nutritional components, and low-GI control components in proportion according to the level of metabolic disorder, and then pack them into composite film bags for sealing and storage using ordinary packaging technology.

Images